{"id":"W131397720","doi":"10.3833/pdr.v2011i5.1473","title":"Mundipharma Gains Commercialisation Rights to Allos Therapeutics’ Folotyn® Outside of North America","year":2011,"lang":"en","type":"article","venue":"PharmaDeals Review","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005223905,0.0002592839,0.0008631024,0.0001642097,0.00007643428,0.000007222564,0.000332618,0.00004142466,0.01002016],"category_scores_gemma":[0.00004781692,0.0002052339,0.0002864751,0.0006189278,0.0001239087,0.00009524167,0.00008293985,0.0002889283,0.00057381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009734927,"about_ca_system_score_gemma":0.00009264651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004592748,"about_ca_topic_score_gemma":0.00004716461,"domain_scores_codex":[0.9975982,0.0003412636,0.0007184636,0.0003371954,0.0005748261,0.0004299953],"domain_scores_gemma":[0.9984167,0.0001138618,0.0002280344,0.0006128134,0.0002824122,0.0003461482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009334626,0.001297704,0.01722693,0.006394162,0.001077192,0.00009434475,0.003928805,0.000001543442,0.04361036,0.000137208,0.02313981,0.9021585],"study_design_scores_gemma":[0.001400004,0.0005211727,0.0155151,0.001652444,0.000731422,0.00003285662,0.00001551335,0.0000321049,0.02396367,0.00007923141,0.9557472,0.0003092434],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4660684,0.3126324,0.002458244,0.02570357,0.001352227,0.02613301,0.0003779931,0.0007798936,0.1644942],"genre_scores_gemma":[0.7131271,0.2409508,0.00189988,0.04114297,0.0003782184,0.0003931728,0.0001609054,0.0001131314,0.001833746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9326074,"threshold_uncertainty_score":0.9908848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2517164448078097,"score_gpt":0.4365977792055006,"score_spread":0.1848813343976909,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}